Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone replacement therapy: reassessing the risks and benefits.

D Shoupe1

  • 1University of Southern California School of Medicine, Los Angeles, USA.

Hospital Practice (1995)
|August 25, 1999
PubMed
Summary

Hormone replacement therapy offers a survival advantage, outweighing breast cancer risks for most postmenopausal women. Benefits include reduced cardiovascular and fracture deaths, even for those with a family history of breast cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hormone replacement therapy: consensus and controversies.

Panminerva medica·2014
Same author

Individualizing hormone-therapy according to cardiovascular risk.

Minerva ginecologica·2013
Same author

Individualizing hormone-therapy according to cardiovascular risk.

Minerva medica·2012
Same author

Comparison of estrogen and androgen levels after oral estrogen replacement therapy.

The Journal of reproductive medicine·2002
Same author

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

Annals of internal medicine·2001
Same author

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.

Fertility and sterility·2001

Area of Science:

  • Reproductive Endocrinology
  • Gerontology
  • Oncology

Background:

  • The relationship between postmenopausal hormone use and breast cancer remains unclear.
  • Hormone replacement therapy (HRT) is widely used for menopausal symptom management.
  • Assessing the overall survival impact of HRT is crucial for clinical decision-making.

Purpose of the Study:

  • To evaluate the net survival benefit of hormone replacement therapy in postmenopausal women.
  • To compare mortality risks associated with HRT, including breast cancer, cardiovascular events, and fractures.

Main Methods:

  • Review of existing literature and epidemiological data on hormone replacement therapy.
  • Comparative analysis of mortality rates across different HRT regimens and patient subgroups.
  • Risk-benefit assessment considering cardiovascular, fracture, and breast cancer outcomes.

Main Results:

  • Hormone replacement therapy confers a significant survival advantage.
  • Cardiovascular and fracture-related deaths substantially exceed breast cancer deaths in HRT users.
  • Low-potency estrogen replacement likely benefits even women with a family history of breast cancer.

Conclusions:

  • The survival benefits of hormone replacement therapy are definitive and outweigh potential breast cancer risks for the majority of postmenopausal women.
  • HRT, particularly low-potency estrogen, should be considered for improving overall survival and reducing major morbidities.
  • Further research should focus on personalized HRT strategies based on individual risk profiles.

Related Experiment Videos